Status: Not yet recruiting
Phase Ib, Randomized, Double-blind, Placebo-Controlled, Dose-Escalation Study of Alpha-0261 Tablets to Assess Safety and Tolerability in Patients With Chronic Spontaneous Urcaria (Part 1) and Food Effect in Healthy Adults (Part 2).
This is a randomized, double-blind, placebo-controlled phase 1b clinical study to evaluate the safety, tolerability, pharmacokinetics and preliminary efficacy of Alpha-0261 Tablets in healthy Chinese adults and in patients with chronic spontaneous urticaria.
Participants needed: 48
Trial details
Phase: Phase 1Age: 18-75Biological sex: AllType: InterventionalSponsor: AlphaMol Science Ltd. (Shanghai)Updated: Jul 6, 2026Locations: 1
Eligibility criteria
Written informed consent must be obtained before any assessment is performed.(Pa... [+6]
Inducible urticaria with identifiable triggers, including dermographism, cold co... [+5]